Home Tags Pembrolizumab

Tag: pembrolizumab

Senior woman with lung cancer during medical visit

WCLC 2019: Updates from the Pembrolizumab Clinical Development Program

Peter Hofland, Ph.D -

Europe Adopts Pembrolizumab + Axitinib as First-Line Treatment for Advanced Renal...

Peter Hofland, Ph.D -

Pembrolizumab + Chemotherapy meets Primary Endpoint in Pivotal Phase III Trial...

Peter Hofland, Ph.D -
Low magnification micrograph of hepatocellular carcinoma the most common form of primary liver cancer. Features on image: End-stage cirrhosis - blue collagen (fibrosis); Mallory bodies; Loss of normal liver architecture; Nuclear atypia.

Breakthrough Therapy Designation for Pembrolizumab + Lenvatinib in Hepatocellular Carcinoma

Peter Hofland, Ph.D -
Merck | MSD Exhibition booth at the 2019 annual meeting of the American Society of Medical Oncology (ASCO).

FDA Accepts Supplemental Biologics License Applications for Pembrolizumab

Peter Hofland, Ph.D -

Pembrolizumab as 1st-line Therapy for Merkel Cell Carcinoma Shows Improved Survival

Peter Hofland, Ph.D -

Interim Phase II Results of DNX-2401 + Pembrolizumab for Glioblastoma ...

Danielle Garcia -

Pembrolizumab Improves Survival of Patients with Metastatic or Recurrent Head and...

Peter Hofland, Ph.D -

Nivolumab + Low-dose Ipilimumab may be First Line Treatment in Some...

Sonia Portillo -

Combination of DKN-01 and Pembrolizumab in Esophagogastric Cancer Shows Promise

Peter Hofland, Ph.D -
12Page 1 of 2

LATEST

© 2019 Sunvalley Communication, LLC. All Rights Reserved.